Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.

Hdl Handle:
http://hdl.handle.net/10147/254896
Title:
Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
Authors:
Greally, Peter; Whitaker, Paul; Peckham, Daniel
Affiliation:
National Children's Hospital, Tallaght, Dublin, Ireland. Peter.Greally@amnch.ie
Citation:
Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis. 2012, 28 (6):1059-67 Curr Med Res Opin
Publisher:
Current medical research and opinion
Journal:
Current medical research and opinion
Issue Date:
Jun-2012
URI:
http://hdl.handle.net/10147/254896
DOI:
10.1185/03007995.2012.674500
PubMed ID:
22401602
Abstract:
Pseudomonas aeruginosa (Pa) is the predominant pathogen infecting the airways of patients with cystic fibrosis (CF). Initial colonization is usually transient and associated with non-mucoid strains, which can be eradicated if identified early. This strategy can prevent, or at least delay, chronic Pa infection, which eventually develops in the majority of patients by their late teens or early adulthood. This article discusses the management and latest treatment developments of Pa lung infection in patients with CF, with a focus on nebulized antibiotic therapy.
Item Type:
Article
Language:
en
MeSH:
Administration, Inhalation; Anti-Bacterial Agents; Chronic Disease; Cystic Fibrosis; Drug Resistance, Bacterial; Humans; Models, Biological; Pseudomonas Infections; Pseudomonas aeruginosa; Respiratory Tract Infections
ISSN:
1473-4877

Full metadata record

DC FieldValue Language
dc.contributor.authorGreally, Peteren_GB
dc.contributor.authorWhitaker, Paulen_GB
dc.contributor.authorPeckham, Danielen_GB
dc.date.accessioned2012-12-07T11:43:59Z-
dc.date.available2012-12-07T11:43:59Z-
dc.date.issued2012-06-
dc.identifier.citationChallenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis. 2012, 28 (6):1059-67 Curr Med Res Opinen_GB
dc.identifier.issn1473-4877-
dc.identifier.pmid22401602-
dc.identifier.doi10.1185/03007995.2012.674500-
dc.identifier.urihttp://hdl.handle.net/10147/254896-
dc.description.abstractPseudomonas aeruginosa (Pa) is the predominant pathogen infecting the airways of patients with cystic fibrosis (CF). Initial colonization is usually transient and associated with non-mucoid strains, which can be eradicated if identified early. This strategy can prevent, or at least delay, chronic Pa infection, which eventually develops in the majority of patients by their late teens or early adulthood. This article discusses the management and latest treatment developments of Pa lung infection in patients with CF, with a focus on nebulized antibiotic therapy.en_GB
dc.language.isoenen
dc.publisherCurrent medical research and opinionen_GB
dc.rightsArchived with thanks to Current medical research and opinionen_GB
dc.subject.meshAdministration, Inhalation-
dc.subject.meshAnti-Bacterial Agents-
dc.subject.meshChronic Disease-
dc.subject.meshCystic Fibrosis-
dc.subject.meshDrug Resistance, Bacterial-
dc.subject.meshHumans-
dc.subject.meshModels, Biological-
dc.subject.meshPseudomonas Infections-
dc.subject.meshPseudomonas aeruginosa-
dc.subject.meshRespiratory Tract Infections-
dc.titleChallenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.en_GB
dc.typeArticleen
dc.contributor.departmentNational Children's Hospital, Tallaght, Dublin, Ireland. Peter.Greally@amnch.ieen_GB
dc.identifier.journalCurrent medical research and opinionen_GB
dc.description.provinceLeinsteren

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.